Clinical Trial Update: A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of depemokimab versus placebo in adults and adolescents with at-risk type 2 asthma, currently not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Depemokimab (depemokimab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: NOT_YET_RECRUITING